CompletedNot Applicable

The Value of PSP in Predicting Outcome in ICU Surgical Peritonitis Patients

Germany137 participantsStarted 2007-07

Plain-language summary

The purpose of this study is to determine the diagnostic accuracy of Pancreatic Stone Protein (PSP) in predicting patient outcomes with suspected peritonitis in the Intensive Care Unit after abdominal surgery and compare PPS with other blood parameters, including C-Reactive Protein (CRP), White Cell Count (WCC), Interleucin-6 (IL-6) and Procalcitonin (PCT).

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Abdominal surgery. * Admission to the Intensive Care Unit (ICU). * Blood sampling within 3 hours from admission to the ICU * Patient over 18 years of age Exclusion Criteria: * Patients already treated for peritonitis. * Patients referred from other hospitals with suspicion of peritonitis * Patient age less than 18 years of age.

What they're measuring

Localization of Peritonitis

Timeframe: up to 2 months

Trial details

NCT IDNCT01465711

SponsorUniversity of Magdeburg

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-12

View on ClinicalTrials.gov More Peritonitis trials